Carregant...
Cases of ALK-rearranged lung cancer with 5-year progression-free survival with crizotinib as initial precision therapy
Guardat en:
| Publicat a: | J Thorac Oncol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659921/ https://ncbi.nlm.nih.gov/pubmed/28611010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2017.06.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|